ClinicalTrials.gov
ClinicalTrials.gov Menu

Adjuvant Treatment of Prostate Cancer With Docetaxel or Not After Radical Radiotherapy (AdRad)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00653848
Recruitment Status : Active, not recruiting
First Posted : April 7, 2008
Last Update Posted : April 26, 2018
Sponsor:
Collaborator:
Sanofi
Information provided by (Responsible Party):
Scandinavian Prostate Cancer Group

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : August 30, 2020
  Estimated Study Completion Date : August 30, 2020